| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/14/2002 | WO2001058951A3 Water-soluble ligand-binding proteins of ligand-gated ion channels, crystals thereof and their use for screening ligands of ligand-gated ion channels |
| 02/14/2002 | WO2001058922A3 Method and compositions for treating hepatocellular cancer |
| 02/14/2002 | WO2001058921A3 Methods and compositions for generating angiostatin |
| 02/14/2002 | WO2001058915A3 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 02/14/2002 | WO2001057248A3 Polynucleotide arrays and their use in sequencing |
| 02/14/2002 | WO2001057210A3 Use of dendroaspin as a vehicle for non-dendroaspin domains |
| 02/14/2002 | WO2001055346A3 System for the internal qualitative and quantitative validation of marker indices |
| 02/14/2002 | WO2001055302A3 Nucleic acids, proteins, and antibodies |
| 02/14/2002 | WO2001054814A3 Compositions and methods for performing biological reactions |
| 02/14/2002 | WO2001053494A3 Cloning and overexpression vanadium bromoperoxidase from marine algae |
| 02/14/2002 | WO2001051646A3 Methods for producing a polypeptide using a crippled translational initiator sequence |
| 02/14/2002 | WO2001051626A3 Novel plasmid expression vectors |
| 02/14/2002 | WO2001051619A3 Genetically modified fibroblast cell |
| 02/14/2002 | WO2001049833A3 Recombinant pinoresinol/lariciresinol reductase, recombinant dirigent protein, and methods of use |
| 02/14/2002 | WO2001048175A3 METHODS FOR PRODUCING ENANTIOMERICALLY PURE α-SUBSTITUTED CARBOXYLIC ACIDS |
| 02/14/2002 | WO2001048161A3 Human heparanase-related polypeptide and nucleic acid |
| 02/14/2002 | WO2001047956A3 Method for obtaining proteins having improved functional characteristics |
| 02/14/2002 | WO2001046419A3 Mammalian prion proteins; related reagents and methods |
| 02/14/2002 | WO2001046393A3 Aspartate kinase |
| 02/14/2002 | WO2001044502A3 Genetic variants of the human fsh receptor and the influence thereof on gametogenesis |
| 02/14/2002 | WO2001042464A3 Human preoptic regulatory factor-2 and uses thereof |
| 02/14/2002 | WO2001042288A3 G-protein coupled receptors |
| 02/14/2002 | WO2001042287A3 Putative human g-protein coupled receptors |
| 02/14/2002 | WO2001038362A3 Production of vaccines |
| 02/14/2002 | WO2001037852A3 Methods of inhibiting atrophy or promoting hypertrophy |
| 02/14/2002 | WO2001036620A3 Vectors and transgenies with regulatory elements for gene delivery to the liver |
| 02/14/2002 | WO2001036589A3 Human ex vivo immune system |
| 02/14/2002 | WO2001029222A3 Polypeptides having phospholipase b activity and nucleic acids encoding same |
| 02/14/2002 | WO2001023595A3 Reduced gravity transformation process and product |
| 02/14/2002 | WO2001021771A3 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents |
| 02/14/2002 | WO2001014418A3 p193 PROTEINS AND NUCLEIC ACIDS, AND USES THEREOF |
| 02/14/2002 | WO2000073337A9 Polymer conjugates of hedgehog proteins and uses |
| 02/14/2002 | WO2000068258A3 Compounds exhibiting an antibiotic activity |
| 02/14/2002 | WO2000067698A3 Method for controlling the fidelity and execution of reverse transcriptase by incorporating and polymerising nucleotide analogues acceptable as substrates without blocking its elongation |
| 02/14/2002 | WO2000065063A9 Nucleic acid vaccines against rickettsial diseases and methods of use |
| 02/14/2002 | WO2000065062A3 Genome sequence and polypeptides of pyrococcus abissy, fragment and uses thereof |
| 02/14/2002 | WO2000060933A9 Pkc induced targets |
| 02/14/2002 | WO2000046366A9 Isolation of nucleic acid molecules |
| 02/14/2002 | WO2000044908A9 Comp/tsp-1, comp/tsp-2 and other tsp chimeric proteins |
| 02/14/2002 | WO2000009552A9 Secreted proteins and polynucleotides encoding them |
| 02/14/2002 | WO1997020938A3 Cells with hybrid receptor and gene construct which can be controlled by said hybrid receptor, and use of said cells in gene therapy |
| 02/14/2002 | US20020019999 Endoglucanase gene promoter upregulated by the root-knot nematode |
| 02/14/2002 | US20020019998 Nucleic acids which code enzymatic polypeptide asssociated with sucrose utilization in plants; for use in prevention of frost damage in agricultural plants |
| 02/14/2002 | US20020019997 Forages |
| 02/14/2002 | US20020019996 Nucleotide sequences associated with response to gravity in plants; for use in the generation of plant organs |
| 02/14/2002 | US20020019995 Nod factor binding protein from legume roots |
| 02/14/2002 | US20020019993 Full term development of animals from enucleated oocytes reconstituted with adult somatic cell nuclei |
| 02/14/2002 | US20020019992 Transgenic non-human mammals with progressive neurologic disease |
| 02/14/2002 | US20020019520 CBFBGA09: a human SL15 homolog |
| 02/14/2002 | US20020019519 KIAA0551 polynucleotides and polypeptides use |
| 02/14/2002 | US20020019518 A sublancin peptide variant (lantibody) having a spacer region and a subtilin leader peptide to provide an anchoring means for inserting and retaining the lantibody in a host cell wall; genetic engineering; bactericides; viricides; kits |
| 02/14/2002 | US20020019517 Fibronectins for use as diagnostic and treatment tools in gene therapy |
| 02/14/2002 | US20020019515 Novel spoIIIE |
| 02/14/2002 | US20020019514 Nucleotide sequences coding fusion protein for use in the detection and treatment of diabetes, autoimmune disease and arthritis |
| 02/14/2002 | US20020019359 Oligonucleotide with a base sequence complementary to a target portion of a nucleic acid encoding angiogenin |
| 02/14/2002 | US20020019350 Targeted angiogenesis |
| 02/14/2002 | US20020019348 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 02/14/2002 | US20020019342 In vitro modification of glycosylation patterns of recombinant glycopeptides |
| 02/14/2002 | US20020019337 Treatment of fruits or vegetables with hypersensitive response elicitor to inhibit postharvest disease or desiccation |
| 02/14/2002 | US20020019052 FACS assisted methods for introducing individual chromosomes into cells |
| 02/14/2002 | US20020019051 Chimeric adenoviral vectors |
| 02/14/2002 | US20020019050 Hybrid microorganism for use in gene therapy |
| 02/14/2002 | US20020019049 Methods for enhancing the expression of a protein of interest by recombinant host cells |
| 02/14/2002 | US20020019046 Generating preferential aggregations; prepare suspension of stem cells, plate on solid surface, harvest aggregations |
| 02/14/2002 | US20020019041 Storing adenoviruses; preparing liquid composition, maintain liquid at freezing, monitor adenovirues for activity |
| 02/14/2002 | US20020019040 Apoptin-associating protein |
| 02/14/2002 | US20020019033 Polynucleotides encoding chemokine beta-15 |
| 02/14/2002 | US20020019030 25324, 50287, 28899, 47007, and 42967 transferase family members and uses therefor |
| 02/14/2002 | US20020019029 Protein; for use in the treatment of cancer, cardiovascular disorders and nervous system disorders |
| 02/14/2002 | US20020019028 Peptide; for use in the treatment of defects associated with polypeptide transfer |
| 02/14/2002 | US20020019006 Detecting nucleotide sequences coding preferentially associating polypeptide; obtain pasimid nucleotide sequences, incubate with probe, detect hybridized probe, recover hybridized nucleotide sequences |
| 02/14/2002 | US20020019005 Process for identification of genes encoding proteins having cell proliferation-promoting activity |
| 02/14/2002 | US20020019000 Polynucleotides coexpressed with matrix-remodeling genes |
| 02/14/2002 | US20020018998 System for simple nucleic acid analysis |
| 02/14/2002 | US20020018992 Detecting nucleotide sequences coding preferential polypeptides; provide cells, transform with expression vectors, detect expression from reporter molecules, recover cells expressing preferential gene |
| 02/14/2002 | US20020018990 Reagents and methods useful for detecting diseases of the breast |
| 02/14/2002 | US20020018989 Method of identifying pharmaceuticals from plant extracts |
| 02/14/2002 | US20020018785 Methods for producing polynucleotide libraries in vaccinia virus |
| 02/14/2002 | US20020018784 Vaccine against mumps containing a jeryl-lynn virus strain |
| 02/14/2002 | US20020018782 Binding to antibodies; prophylaxis, therapy of infections |
| 02/14/2002 | US20020018779 Non-anaphylactic forms of allergens and their use |
| 02/14/2002 | US20020018775 Complexing; separation; gene therapy |
| 02/14/2002 | US20020018769 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA |
| 02/14/2002 | US20020018767 Transformation; gene expression |
| 02/14/2002 | US20020018766 Genes differentially expressed in cancer cells to design cancer vaccines |
| 02/14/2002 | US20020018750 Anticancer agents |
| 02/14/2002 | US20020018749 High avidity polyvalent and polyspecific reagents |
| 02/14/2002 | US20020018736 Method and apparatus for automatically removing vector unit in DNA base sequence |
| 02/14/2002 | US20020018199 Imaging of biological samples using electronic light detector |
| 02/14/2002 | DE10038237A1 Verfahren zum Nachweis von Mutationen in Nucleotidsequenzen A method for detecting mutations in nucleotide sequences |
| 02/14/2002 | DE10037861A1 Composition for treating malignant disease, useful especially for cervical carcinoma, contains agent that inhibits activity of nucleolin |
| 02/14/2002 | DE10037612A1 New phosphopentose isomerase gene from Coryneform bacteria, useful for transforming cells for improved fermentative production of L-amino acids, especially lysine |
| 02/14/2002 | DE10037611A1 New ribulose-phosphate 3-epimerase gene from coryneform bacteria, useful for transforming cells for improved fermentative production of L-amino acids, especially lysine |
| 02/14/2002 | DE10037270A1 Silicatein-vermittelte Synthese von amorphen Silikaten und Siloxanen und ihre Verwendung Silicatein-mediated synthesis of amorphous silicates and siloxanes and their use |
| 02/14/2002 | CA2820132A1 2,5-dkg permeases |
| 02/14/2002 | CA2634294A1 Production of humanized antibodies in transgenic animals |
| 02/14/2002 | CA2453907A1 Association of sim2 with cancer |
| 02/14/2002 | CA2423519A1 A new slit-like protein obtained from a cdna library from hs-5 stromal cell line |
| 02/14/2002 | CA2422155A1 Production of humanized antibodies in transgenic animals |
| 02/14/2002 | CA2418952A1 A novel member of the lysyl oxidase gene family |